Other

J&J Q3 net income drops 7 percent on higher costs

Johnson & Johnson's third-quarter profit fell 7 percent as increased research and production costs offset higher sales for its medicines and medical devices and new revenue from its biggest acquisition ever.

Medications

J&J tries new cap to curb fatal Tylenol overdoses

Bottles of Tylenol sold in the U.S. will soon bear red warnings alerting users to the potentially fatal risks of taking too much of the popular pain reliever. The step, disclosed by the maker of Tylenol, comes amid lawsuits ...

page 2 from 4